Cargando…
The role of the ubiquitination–proteasome pathway in breast cancer: Ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer
Aberrant activity of growth factor receptors has been implicated in the pathogenesis of a wide variety of malignancies. The negative regulation of signaling by growth factor receptors is mediated in large part by the ubiquitination, internalization, and degradation of the activated receptor. Over th...
Autor principal: | Lipkowitz, Stan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154127/ https://www.ncbi.nlm.nih.gov/pubmed/12559039 http://dx.doi.org/10.1186/bcr541 |
Ejemplares similares
-
The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
por: Orlowski, Robert Z, et al.
Publicado: (2003) -
The ubiquitin-proteasome pathway in cancer.
por: Spataro, V., et al.
Publicado: (1998) -
The role of the ubiquitination–proteasome pathway in breast cancer: Use of mouse models for analyzing ubiquitination processes
por: Rossi, Sabrina, et al.
Publicado: (2003) -
Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021) -
The Roles of Ubiquitin-Binding Protein Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome System and Autophagy
por: Zientara-Rytter, Katarzyna, et al.
Publicado: (2019)